Abstract

.In late 2017, Madagascar experienced a large urban outbreak of pneumonic plague, the largest outbreak to date this century. During the outbreak, there were widespread reports of plague patients presenting with atypical symptoms, such as prolonged duration of illness and upper respiratory tract symptoms. Reported mortality among plague cases was also substantially lower than that reported in the literature (25% versus 50% in treated patients). A prospective multicenter observational study was carried out to investigate potential reasons for these atypical presentations. Few subjects among our cohort had confirmed or probable plague, suggesting that, in part, there was overdiagnosis of plague cases by clinicians. However, 35% subjects reported using an antibiotic with anti-plague activity before hospital admission, whereas 55% had antibiotics with anti-plague activity detected in their serum at admission. Although there may have been overdiagnosis of plague by clinicians during the outbreak, the high frequency of community antibiotic may partly explain the relatively few culture-positive sputum samples during the outbreak. Community antibiotic use may have also altered the clinical presentation of plague patients. These issues make accurate detection of patients and the development of clinical case definitions and triage algorithms in urban pneumonic plague outbreaks difficult.

Highlights

  • On August 27, 2017, a 31-year-old man with pneumonic plague boarded a taxi in the central highlands of Madagascar, heading to the eastern city of Toamasina, via the capital, Antananarivo.[1]

  • Pneumonic plague can occur as a result of hematogenous dissemination of bacteria from buboes to the lungs, or from human-tohuman respiratory transmission via droplets.[4]

  • The specific objectives of the study were to 1) identify the clinical symptoms and biological markers associated with pneumonic plague; 2) identify the factors associated with atypical manifestations of pneumonic plague; 3) estimate the case fatality rate among hospitalized pneumonic plague patients, and identify the clinical, therapeutic, and biological factors associated with death; and 4) estimate the sensitivity and specificity of the F1 rapid diagnostic test (RDT) for diagnosing of pneumonic plague

Read more

Summary

Introduction

On August 27, 2017, a 31-year-old man with pneumonic plague boarded a taxi in the central highlands of Madagascar, heading to the eastern city of Toamasina, via the capital, Antananarivo.[1] He died on route. A large cluster of infections subsequently occurred among his contacts, with onward transmission in those cities.[1] The outbreak was eventually declared over on November 27, 2017, after 2,414 suspect cases had been identified (of which 418 were confirmed/probable).[2] This was the first urban outbreak of pneumonic plague this century. Plague is caused by the Gram-negative bacteria Yersinia pestis. An outbreak of pneumonic plague occurs when an index case with secondary pneumonic plague infects others, resulting in cases of primary pneumonic plague (secondary cases), who in turn themselves infect others (tertiary cases)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call